Order Article Reprints

Ahn B-C, Lee JH, Kim MH, Pyo K-H, Lee C-k, Lim SM, Kim HR, Cho BC, Hong MH. Distinct Characteristics and Clinical Outcomes to Predict the Emergence of MET Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. Cancers. 2021; 13(12):3096. https://doi.org/10.3390/cancers13123096

Ahn, Beung-Chul, Ji Hyun Lee, Min Hwan Kim, Kyoung-Ho Pyo, Choong-kun Lee, Sun Min Lim, Hye Ryun Kim, Byoung Chul Cho, and Min Hee Hong. 2021. "Distinct Characteristics and Clinical Outcomes to Predict the Emergence of MET Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors" Cancers 13, no. 12: 3096. https://doi.org/10.3390/cancers13123096

Ahn, B.-C., Lee, J. H., Kim, M. H., Pyo, K.-H., Lee, C.-k., Lim, S. M., Kim, H. R., Cho, B. C., & Hong, M. H. (2021). Distinct Characteristics and Clinical Outcomes to Predict the Emergence of MET Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. Cancers, 13(12), 3096. https://doi.org/10.3390/cancers13123096